<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04810819</url>
  </required_header>
  <id_info>
    <org_study_id>contrast-2021</org_study_id>
    <nct_id>NCT04810819</nct_id>
  </id_info>
  <brief_title>Clinical Study of the Effect of Methylprednisolone Combined</brief_title>
  <official_title>Clinical Study of the Effect of Methylprednisolone Combined With Two Hydroxypropyl Theophylline on Respiratory Dynamics During Thoracoscopic Lobectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Qianfoshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Qianfoshan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Through the design of RCT study, the preoperative use of drugs (methylprednisolone +&#xD;
      dihydroxypropyltheophylline) as intervention measures, the patients undergoing thoracoscopic&#xD;
      lobectomy as the main research object, through the comparison of two groups of patients with&#xD;
      intraoperative respiratory dynamics index and postoperative complications, to explore a more&#xD;
      effective perioperative management method.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pplat</measure>
    <time_frame>5 different time points during the operation</time_frame>
    <description>Airway pressure at different time points during operation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ppeak</measure>
    <time_frame>5 different time points during the operation</time_frame>
    <description>Peak airway pressure at different time points during operation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Methylprednisolone;Dihydroxypropyltheophylline;One Lung Ventilation;Respiratory Dynamics</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone 40 MG Injection;Dihydroxypropyltheophylline;</intervention_name>
    <description>Before anesthesia induction, 80 mg methylprednisolone and 100 ml saline were given intravenously, and 0.25 g dihydroxypropyltheophylline and 100 ml normal saline were given intravenously.</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1. After fully understanding the purpose and significance of the trial, the patients&#xD;
             voluntarily participated in the trial and signed the informed consent;&#xD;
&#xD;
             2. The type of operation was general anesthesia and thoracoscopic lobectomy;&#xD;
&#xD;
             3. Age 18-75 years old, including boundary value, gender is not limited;&#xD;
&#xD;
             4. BMI 18-26kg / m2;&#xD;
&#xD;
             5. ASA grade I-II; no mental disorder, normal consciousness, normal communication;&#xD;
&#xD;
             6. No contraindications of methylprednisolone and dihydroxypropyltheophylline.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1. There were diseases of immune, endocrine, nervous and mental system before&#xD;
             operation, and serious dysfunction of heart, liver and kidney;&#xD;
&#xD;
             2. Take immunosuppressive drugs and non steroidal anti-inflammatory drugs before&#xD;
             operation;&#xD;
&#xD;
             3. Respiratory tract infection (cough, expectoration, suffocation, etc.) in recent 1&#xD;
             month; pneumonia, bronchitis, etc. on CT;&#xD;
&#xD;
             4. History of chronic pulmonary disease, including but not limited to asthma,&#xD;
             pulmonary abscess, tuberculosis, chronic bronchitis, etc;&#xD;
&#xD;
             5. FEV1 &lt; 50%;&#xD;
&#xD;
             6. Oxygen saturation was lower than 90% and airway pressure was higher than 40 cm H20;&#xD;
&#xD;
             7. Continuous hypotension or hypertension during the operation; intraoperative blood&#xD;
             loss &gt; 1000ml;&#xD;
&#xD;
             8. Allergic to methylprednisolone or dihydroxypropyltheophylline;&#xD;
&#xD;
             9. There are any other situations that the researchers think are not suitable for&#xD;
             inclusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 21, 2021</study_first_submitted>
  <study_first_submitted_qc>March 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2021</study_first_posted>
  <last_update_submitted>June 15, 2021</last_update_submitted>
  <last_update_submitted_qc>June 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Qianfoshan Hospital</investigator_affiliation>
    <investigator_full_name>Lili Cao</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Acetate</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Dyphylline</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

